Select a date and time slot to book an Appointment
Date Of Appointment
Here's an overview of the latest developments: 🧪 Emerging Medications 1. MM120 (LSD-based therapy) Developed by MindMed, MM120 is undergoing Phase 3 clinical trials for Generalized Anxiety Disorder (GAD). Early results indicate rapid and sustained symptom relief, positioning it as a potential breakthrough in anxiety treatment. 2. Exxua & Zuranolone These novel antidepressants are designed to act swiftly with fewer side effects compared to traditional SSRIs. Zuranolone, in particular, h...
This site was designed with Websites.co.in - Website Builder
We appreciate you contacting us. Our support will get back in touch with you soon!
Have a great day!
Please note that your query will be processed only if we find it relevant. Rest all requests will be ignored. If you need help with the website, please login to your dashboard and connect to support